Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.72M Sell
11,830
-451
-4% -$62.3K 1.13% 22
2026
Q2
$1.58M Buy
12,281
+765
+7% +$89.5K 1.05% 24
2026
Q1
$1.39M Buy
11,516
+547
+5% +$63.2K 1.13% 22
2025
Q4
$1.15M Buy
+10,969
New +$1.03M 0.94% 29

Other funds holding MRK

Adelphi Trust's MRK Position: Q3 2026 in Review

Adelphi Trust reduced its Merck (MRK) stake by 3.7% in Q3 2026, selling an estimated $62.3K and leaving 11,830 shares worth $1.72M. The position accounts for 1.13% of the portfolio, ranked #22.

Adelphi Trust first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 42 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Adelphi Trust held 11,830 shares of Merck worth $1.72M as of Q3 2026.
  • Adelphi Trust sold 451 Merck shares in Q3 2026, an estimated $62.3K.
  • Merck made up 1.13% of Adelphi Trust's portfolio in Q3 2026, its #22 holding.
  • Adelphi Trust first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 42 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Adelphi Trust's 13F filing for Q3 2026, filed 5 Oct 2026.